Samvardhana Motherson International Ltd

Q2 FY23 Earnings Call Analysis

Auto Components

Full Stock Analysis
fundraise: Yescapex: Yesrevenue: Category 2margin: Category 3orderbook: Yes
💰

fundraise

Any current/future new fundraising through debt or equity?

- No explicit mention of current or planned equity fundraising in the transcript. - Debt levels have increased in Q1 mainly due to seasonal working capital buildup and acquisition payments. - Leveraging remains below 2x, indicating comfort with current debt levels despite recent acquisitions. - Pending acquisitions expected to add $1.4 billion in revenues next year and will be integrated gradually. - Management is cautiously monitoring market conditions and has not indicated any immediate plans to raise new debt or equity. - Conversations around cost pressures and pricing continue, but no direct fundraising is highlighted. - The company is focused on organic growth, operational improvements, and integrating acquisitions rather than raising new capital currently. Hence, based on the call, there are no announced plans for new fundraising through debt or equity at this time.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- Significant CAPEX already done for the current order book announced last quarter. - Current investments are focused on future growth driven by new orders and acquisitions. - Future CAPEX expected to be at the upper band of Rs. 3,300 crores based on growth momentum. - New acquisitions bring in additional CAPEX requirements as they integrate into the business. - Seven new Greenfield plants are being set up in emerging markets (6 in India, 1 in China). - CAPEX plans may be reevaluated based on progress and impact of ongoing M&As. - Capacity expansion strategy includes adding new plants once existing ones hit 75-80% utilization to maintain flexibility. - Acquisitions expected to add substantial revenues and will be cash EPS accretive, supporting further strategic investments.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- The company expects continued growth driven by premiumization and industry trends favoring their products. - They are optimistic about the next 12 to 24 months despite ongoing uncertainties. - Growth is supported by new orders and acquisitions, with three pending M&As expected to add $1.4 billion in revenues next year. - Organic growth remains strong, with a 27% year-on-year revenue increase in the recent quarter. - Capacity expansion is aligned with customer outlook and future growth opportunities, with new Greenfield plants planned as utilization approaches 80%. - Automotive industry volumes are still below pre-COVID levels, with a 15%-20% upside expected as production normalizes. - The focus remains on sustainable profitability and working closely with customers to navigate inflationary and supply challenges. - Overall, the company is well-positioned for steady double-digit volume and revenue growth ahead.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- The company expects continued strong growth, reflected by a 27% revenue increase and 64% EBITDA growth year-on-year in the recent quarter. - Earnings growth is supported by organic expansion and upcoming acquisitions expected to add significant revenue ($1.4 billion next year). - The management is optimistic about the next 12-24 months, anticipating improved business conditions and better profitability. - Capacity utilization is managed conservatively to enable agile growth, avoiding overcapacity strain which supports sustained operational efficiency. - Margin improvements are driven by operating leverage, premiumisation trends, and price adjustments to manage inflation and wage pressures. - Ongoing efforts to improve "red unit" health and settlements with customers aim to sustain profitability improvements. - The company plans capex around Rs. 3,300 crores, potentially revised upward with new acquisitions, fueling future growth. - All recent M&A activities are strategic and EPS accretive, expected to boost consolidated profits going forward.
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

- The company's current order book is substantially covered for existing capacity; capacity utilization is broad due to thousands of products. - CAPEX is primarily for future growth, new orders, and acquisitions. - Three pending acquisitions—Cirma (aerospace), Yachiyo (Honda San), and Dr. Schneider—are expected to add USD 1.4 billion in revenues next year. - These pending deals are subject to antitrust approvals and closing formalities. - The company has added 41 new facilities and about 8,500 employees from recent acquisitions. - They anticipate nearly USD 5 billion in gross revenue additions and about USD 1.1 billion net from recent M&A integration. - Management expects future growth driven by strategic positioning, premiumization, and increasing value content. - The outlook for the next 12 to 24 months is optimistic despite near-term uncertainties.